HIV Clinical Trials 2024

HIV Clinical Trials 2024

HIV research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in human immunodeficiency virus clinical trials today.

HIV Clinical Trials

Here are the 6 most popular medical studies for hiv

Popular filter options for hiv trials

HIV Clinical Trials

View 18 HIV medical studies.

HIV/AIDS Clinical Trials

View 12 HIV/AIDS medical studies.

Phase 3 Human Immunodeficiency Virus Clinical Trials

View 30 phase 3 human immunodeficiency virus medical studies.

Human Immunodeficiency Virus Clinical Trials With No Placebo

View 30 human immunodeficiency virus medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hiv

What are the top hospitals conducting hiv research?

When it comes to cutting-edge clinical trials in the field of HIV research, several top hospitals are leading the way. The GSK Investigational Sites spread across multiple locations have been at the forefront of this battle against HIV. In Dallas, researchers are currently conducting five active trials for HIV, marking a significant commitment to finding new treatments and solutions for this condition. Similarly, in Toronto, another GSK Investigational Site is actively engaged in five ongoing HIV trials. These sites are dedicated to investigating novel approaches to combat the virus and improve patient outcomes. Meanwhile, Los Angeles boasts four active trials conducted by their own GSK Investigational Site, which focuses on developing innovative strategies and therapies for individuals living with HIV.

In Bakersfield and Orlando as well there exist dynamic institutions focused on contributing significantly towards fighting against this disease through rigorous investigations coordinated by respective local branches of GSK's investigative site; both facilities have initiated four studies each from within their premises aimed explicitly comprehending different aspects associated with prevention or treatment methods designed more efficiently addressing concerns related to HIv.

These committed hospitals reflect a collective determination among researchers worldwide who relentlessly work towards unraveling the complexities surrounding HIV transmission, progression, treatment options while simultaneously aiming at discovering potential breakthroughs that will ultimately lead us closer to eradicating this devastating disease once and for all

Which are the best cities for hiv clinical trials?

When it comes to HIV clinical trials, several cities in the United States and Canada offer exceptional research opportunities. Los Angeles, California leads with 15 active trials studying treatments such as DOR/ISL, GSK3810109A, and Islatravir. Orlando, Florida and Dallas, Texas closely follow with 11 ongoing studies focused on similar interventions. In Canada, both Toronto, Ontario and Montreal, Quebec boast 10 active trials exploring treatments like DOR/ISL and GSK3810109A. These cities serve as vital hubs for groundbreaking research that advances our understanding of HIV treatment options and provides hope for individuals living with this condition.

Which are the top treatments for hiv being explored in clinical trials?

Exciting advancements are underway in HIV research, with one treatment leading the way. Tele-B6 has emerged as a promising contender, currently being explored in an active clinical trial dedicated to HIV. Although it is still early in its journey, with just one all-time trial and first listed in 2023, the potential of this treatment is generating considerable interest and anticipation within the scientific community. As researchers continue their tireless efforts, we eagerly await further developments that could shape the future of HIV treatment.

What are the most recent clinical trials for hiv?

Exciting developments are underway in the realm of HIV research, with recent clinical trials offering new insights and potential treatments. One such trial focuses on participants receiving VH3810109 in combination with Cabotegravir, a Phase 2 study that became available on August 17th, 2023. Another promising trial involves participants receiving DTG/3TC fixed-dose combination (FDC) for HIV, which entered Phase 3 and became available on July 7th and July 6th respectively. Additionally, there have been Phase 3 trials evaluating the efficacy of DOR/ISL as a treatment option for HIV patients; these studies were made accessible to the public on March 17th and February 20th respectively. These groundbreaking clinical investigations hold immense potential in enhancing our understanding of HIV management and bringing us closer to improved outcomes for those living with this condition.

What hiv clinical trials were recently completed?

Several notable clinical trials in the field of HIV have recently concluded, representing significant progress in this area of research. Notably, a trial evaluating the efficacy and safety of a novel antiretroviral therapy completed successfully. This study marks an important milestone in advancing treatment options for individuals living with HIV. Additionally, another trial focusing on innovative prevention strategies has reached its conclusion, offering valuable insights into reducing transmission rates among high-risk populations. These recent clinical trials signify the continuous efforts to enhance our understanding and address the challenges posed by HIV/AIDS.